182 related articles for article (PubMed ID: 1300168)
1. Paraneoplastic cerebellar degeneration: successful early detection and treatment of cancer through characterization of the anti-Purkinje cell antibody.
Tanaka K; Igarashi S; Yamazaki M; Nakajima T; Miyatake T; Sakai K
Intern Med; 1992 Dec; 31(12):1339-42. PubMed ID: 1300168
[TBL] [Abstract][Full Text] [Related]
2. Paraneoplastic cerebellar degeneration with anti-Purkinje cell antibody associated with primary tubal cancer.
Matsushita H; Kodama S; Aoki Y; Tanaka K; Tanaka K; Saito N
Gynecol Obstet Invest; 1998; 45(2):140-3. PubMed ID: 9517809
[TBL] [Abstract][Full Text] [Related]
3. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice.
Tanaka K; Tanaka M; Igarashi S; Onodera O; Miyatake T; Tsuji S
Clin Neurol Neurosurg; 1995 Feb; 97(1):101-5. PubMed ID: 7788964
[TBL] [Abstract][Full Text] [Related]
4. [A case of paraneoplastic cerebellar degeneration--success in early detection of cancer by anti-Purkinje cell antibody].
Igarashi S; Tanaka K; Nakajima T; Yamazaki M; Inuzuka T; Miyatake T
Rinsho Shinkeigaku; 1992 Mar; 32(3):309-13. PubMed ID: 1628454
[TBL] [Abstract][Full Text] [Related]
5. [Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer].
Tanaka K; Tanaka M; Onodera O; Tsuji S
Rinsho Shinkeigaku; 1995 Jul; 35(7):770-4. PubMed ID: 8777801
[TBL] [Abstract][Full Text] [Related]
6. [Paraneoplastic cerebellar degeneration: case report of a patient with breast carcinoma].
Huober J; Niedermaier N; Drlicek M; Kaufmann M; Hacke W; Bastert G
Geburtshilfe Frauenheilkd; 1996 Apr; 56(4):214-6. PubMed ID: 8682288
[TBL] [Abstract][Full Text] [Related]
7. Selective concentration of anti-Purkinje cell antibody in the CSF of two patients with paraneoplastic cerebellar degeneration.
Graus F; Segurado OG; Tolosa E
Acta Neurol Scand; 1988 Sep; 78(3):210-3. PubMed ID: 3227806
[TBL] [Abstract][Full Text] [Related]
8. Anti-Purkinje cells antibodies in two cases of paraneoplastic cerebellar degeneration.
Sindic CJ; Andersson M; Boucquey D; Chalon MP; Bisteau M; Brucher JM; Laterre EC
Acta Neurol Belg; 1993; 93(2):65-77. PubMed ID: 8506746
[TBL] [Abstract][Full Text] [Related]
9. Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration.
Furneaux HM; Rosenblum MK; Dalmau J; Wong E; Woodruff P; Graus F; Posner JB
N Engl J Med; 1990 Jun; 322(26):1844-51. PubMed ID: 2348838
[TBL] [Abstract][Full Text] [Related]
10. [The detection of anti-Purkinje cell antibody (anti-Yo antibody) by ELISA using recombinant Yo fusion protein].
Tanaka K; Tanaka M; Onodera O; Igarashi S; Tsuji S
No To Shinkei; 1994 Jan; 46(1):47-51. PubMed ID: 8136199
[TBL] [Abstract][Full Text] [Related]
11. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell loss.
Tanaka M; Tanaka K; Onodera O; Tsuji S
Clin Neurol Neurosurg; 1995 Feb; 97(1):95-100. PubMed ID: 7788981
[TBL] [Abstract][Full Text] [Related]
12. A variant of the anti-Purkinje cell antibody in a patient with paraneoplastic cerebellar degeneration.
Anderson NE; Budde-Steffen C; Wiley RG; Thurman L; Rosenblum MK; Nadeau SE; Posner JB
Neurology; 1988 Jul; 38(7):1018-26. PubMed ID: 3290700
[TBL] [Abstract][Full Text] [Related]
13. [Paraneoplastic cerebellar degeneration].
Nakano R; Sato S
Nihon Rinsho; 1994 Nov; 52(11):3000-5. PubMed ID: 7996701
[TBL] [Abstract][Full Text] [Related]
14. Paraneoplastic cerebellar degeneration with fallopian tube adenocarcinoma.
Tanaka Y; Suzuki N; Takao M; Ichikawa A; Susumu N; Aoki D
Gynecol Oncol; 2005 Nov; 99(2):500-3. PubMed ID: 16126258
[TBL] [Abstract][Full Text] [Related]
15. Anti-Yo antibody uptake and interaction with its intracellular target antigen causes Purkinje cell death in rat cerebellar slice cultures: a possible mechanism for paraneoplastic cerebellar degeneration in humans with gynecological or breast cancers.
Greenlee JE; Clawson SA; Hill KE; Wood B; Clardy SL; Tsunoda I; Carlson NG
PLoS One; 2015; 10(4):e0123446. PubMed ID: 25885452
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigen.
Jaeckle KA; Graus F; Houghton A; Cardon-Cardo C; Nielsen SL; Posner JB
Ann Neurol; 1985 Nov; 18(5):592-600. PubMed ID: 2416270
[TBL] [Abstract][Full Text] [Related]
17. [61-year-old patient with rapidly progressive cerebellar symptoms].
Becker K; Wurster U; Kienast K; Fischer B
Pneumologie; 1995 Dec; 49(12):700-3. PubMed ID: 8584543
[TBL] [Abstract][Full Text] [Related]
18. Antineural autoantibodies in patients with paraneoplastic cerebellar degeneration.
Tsukamoto T; Yamamoto H; Iwasaki Y; Yoshie O; Terunuma H; Suzuki H
Arch Neurol; 1989 Nov; 46(11):1225-9. PubMed ID: 2818258
[TBL] [Abstract][Full Text] [Related]
19. [Immunobiological approach to spinocerebellar degeneration--anti-Purkinje cell antibodies in paraneoplastic cerebellar degeneration].
Miyatake T
Rinsho Shinkeigaku; 1993 Dec; 33(12):1291-3. PubMed ID: 8174327
[TBL] [Abstract][Full Text] [Related]
20. Antibody to a zinc finger protein in a patient with paraneoplastic cerebellar degeneration.
Sato S; Inuzuka T; Nakano R; Fujita N; Matsubara N; Sakimura K; Mishina M; Miyatake T
Biochem Biophys Res Commun; 1991 Jul; 178(1):198-206. PubMed ID: 1712585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
